Episode Details

Back to Episodes
5.32 - ASH Update #1 - Talquetamab NEJM

5.32 - ASH Update #1 - Talquetamab NEJM

Published 3 years, 8 months ago
Description
Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us